Display Settings:

Format

Send to:

Choose Destination
    Arch Neurol. 2001 Oct;58(10):1682-4.

    Treatment of ballism and pseudobulbar affect with sertraline.

    Source

    Department of Neurology, Emory University, Atlanta, Ga, USA.

    Abstract

    BACKGROUND:

    The pathogenesis of ballism is uncertain and may involve more than one mechanism; treatment is not always efficacious.

    OBJECTIVE:

    To provide evidence of a nondopaminergic mechanism and the potential for a prompt and nearly complete response to a serotonergic agent.

    METHODS:

    Report of 2 separate trials of sertraline hydrochloride in a single patient.

    RESULTS:

    Complete remission of symptoms within 48 hours of each drug trial.

    CONCLUSION:

    Sertraline may offer an alternative with a better adverse effect profile than dopamine receptor blockers in the treatment of patients with ballism.

    PMID:
    11594930
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk